Nexgel (NXGL) Capital Leases (2024 - 2025)
Nexgel (NXGL) posted Capital Leases of $242000.0 for Q4 2025, down 6.56% on a QoQ basis from $259000.0 in Q3 2025, and down 21.17% year-over-year from $307000.0 in Q4 2024.
Nexgel (NXGL) Capital Leases (2024 - 2025) Analysis & Trends
Nexgel's Capital Leases history runs 2 years deep, the most recent figure standing at $242000.0 for Q4 2025.
- Quarterly Capital Leases fell 21.17% year-over-year to $242000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $242000.0 (down 21.17% YoY) and the FY2025 annual result came in at $242000.0, down 21.17% from the prior year.
- Capital Leases was $242000.0 for Q4 2025 at Nexgel, down from $259000.0 in the prior quarter.
- Across five years, Capital Leases topped out at $352000.0 in Q1 2024 and bottomed at $242000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Nexgel | 3.50 Mn | 2.13 Mn | 819,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 242,000.00 |
| Sep 30, 2025 | 259,000.00 |
| Jun 30, 2025 | 275,000.00 |
| Mar 31, 2025 | 293,000.00 |
| Dec 31, 2024 | 307,000.00 |
| Sep 30, 2024 | 323,000.00 |
| Jun 30, 2024 | 339,000.00 |
| Mar 31, 2024 | 352,000.00 |